Lung - Refresher 2021
The management of non-small cell lung cancer has undergone major transformation in the last three years driven by the increasing using of immunotherapy as well as local ablative therapies in advanced stage disease. Translation of these practices into community based setting is important as overall survival in lung cancer has dramatically improved with incorporation of improved treatment. This educational activity will help participants to better apply new treatment strategies so that patient outcomes can be enhanced.
This activity is available from April 5, 2021, through 11:59 p.m. Eastern time on April 4, 2024.
This activity was originally recorded at ASTRO’s virtual 2021 ASTRO Annual Refresher Course, March 19-21, 2021.
The meeting is designed to meet the interests of practicing radiation oncologists, medical oncologists, radiation oncology residents, radiation therapists, radiation dosimetrists, physicists and all other health professionals involved in the field of radiation oncology.
Upon completion of this activity, learners should be able to:
Apply the increasing role of radiotherapy in advance stage lung cancer.
- Describe the instances when radiotherapy for advanced stage disease is not indicated.
Russell Hales, MD is employed by Johns Hopkins University and has no financial relationships with a commercial interest.
The person(s) above served as the developer(s) of this activity. Additionally, the Education Committee had control over the content of this activity. All relevant relationships have been mitigated.
The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council of Continuing Medical Education to provide continuing education to physicians.
ASTRO is awarded Deemed Status by the American Board of Radiology to provide SA-CME as part of Part II Maintenance of Certification.
- 1.50 Certificate of AttendanceThis activity was designated for 1.50 AMA PRA Category 1 Credit™.
- 1.50 SA-CME
The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council of Continuing Medical Education to provide continuing medical education for physicians.
The American Society for Radiation Oncology (ASTRO) designates this Enduring material for a maximum of 1.50 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity meets the American Board of Radiology's criteria for a self-assessment activity in the ABR's Maintenance of Certification program. Participation in this course in combination with the successful completion of the corresponding assessment and course evaluation adheres to the guidelines established by the ABR for 1.50 self-assessment credits.
ASTRO members must log in to the ASTRO website to view and receive the discounted member rate.
- Nonmember: $105
- Member: $55
No refunds, extensions, or substitutions will be made for participants, including those who for any reason, have not completed the course by the end of the qualification date. The qualification date for each course is listed in the course catalog on the ASTRO website under availability.
Participants using ASTRO's online courses to satisfy the requirement of a Maintenance of Certification (MOC) program should verify the number, type and availability dates of any course before making a purchase. No refunds, extensions, or substitutions will be made for participants who have purchased courses that do not align with their MOC requirement.
The course and its materials will only be available on the ASTRO website for that 3 year period regardless of purchase date. At the expiration of the qualification, participants will no longer have access to the course or its materials. ASTRO reserves the right to remove a course before the end of its qualification period.
One of the two latest versions of Google Chrome, Mozilla Firefox, Internet Explorer or Safari.